Nuclear inclusion bodies of mutant and wild-type p53 in cancer: a hallmark of p53 inactivation and proteostasis remodelling by p53 aggregation

被引:53
作者
De Smet, Frederik [1 ,2 ,3 ,4 ]
Rubio, Mirian Saiz [1 ,2 ]
Hompes, Daphne [5 ]
Naus, Evelyne [1 ,2 ]
De Baets, Greet [1 ,2 ]
Langenberg, Tobias [1 ,2 ]
Hipp, Mark S. [6 ]
Houben, Bert [1 ,2 ]
Claes, Filip [1 ,2 ]
Charbonneau, Sarah [3 ]
Blanco, Javier Delgado [1 ,2 ]
Plaisance, Stephane [7 ]
Ramkissoon, Shakti [3 ,8 ,9 ,10 ]
Ramkissoon, Lori [3 ]
Simons, Colinda [11 ]
van den Brandt, Piet [11 ]
Weijenberg, Matty [11 ]
Van England, Manon [12 ]
Lambrechts, Sandrina [13 ]
Amant, Frederic [13 ,14 ]
D'Hoore, Andre [5 ]
Ligon, Keith L. [3 ,4 ,8 ,9 ,10 ,15 ]
Sagaert, Xavier [16 ]
Schymkowitz, Joost [1 ,2 ]
Rousseau, Frederic [1 ,2 ]
机构
[1] Katholieke Univ Leuven, Dept Cellular & Mol Med, Switch Lab, B-3000 Leuven, Belgium
[2] VIB Ctr Brain & Dis Res, B-3000 Leuven, Belgium
[3] Dana Farber Canc Inst, Dept Med Oncol, Ctr Mol Oncol Pathol, Boston, MA 02115 USA
[4] Broad Inst, Cambridge, MA USA
[5] Univ Hosp Gasthuisberg, Dept Abdominal Surg, Leuven, Belgium
[6] Max Planck Inst Biochem, Dept Cellular Biochem, Martinsried, Germany
[7] Flanders Inst Biotechnol VIB, Nucle Core, Leuven, Belgium
[8] Brigham & Womens Hosp, Dept Pathol, Div Neuropathol, 75 Francis St, Boston, MA 02115 USA
[9] Childrens Hosp Boston, Boston, MA USA
[10] Harvard Med Sch, Dept Pathol, Boston, MA USA
[11] Maastricht Univ, Dept Epidemiol, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands
[12] Maastricht Univ, Dept Pathol, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands
[13] Katholieke Univ Leuven, Univ Hosp Leuven, Div Gynaecol Oncol, Dept Obstet & Gynaecol, Leuven, Belgium
[14] Netherlands Canc Inst, Ctr Gynaecol Oncol Amsterdam, Amsterdam, Netherlands
[15] Childrens Hosp Boston, Dept Pathol, Boston, MA USA
[16] Katholieke Univ Leuven, Translat Cell & Tissue Res, Leuven, Belgium
基金
欧洲研究理事会;
关键词
p53; aggregation; proteostasis; colon cancer; glioblastoma; nuclear inclusion bodies; UBIQUITIN-PROTEASOME SYSTEM; HEAT-SHOCK RESPONSE; PROTEIN AGGREGATION; CELLULAR-MODEL; A-BETA; GAIN; PML; MDM2; TARGET; ACCUMULATION;
D O I
10.1002/path.4872
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although p53 protein aggregates have been observed in cancer cell lines and tumour tissue, their impact in cancer remains largely unknown. Here, we extensively screened for p53 aggregation phenotypes in tumour biopsies, and identified nuclear inclusion bodies (nIBs) of transcriptionally inactive mutant or wild-type p53 as the most frequent aggregation-like phenotype across six different cancer types. p53-positive nIBs co-stained with nuclear aggregation markers, and shared molecular hallmarks of nIBs commonly found in neurodegenerative disorders. In cell culture, tumour-associated stress was a strong inducer of p53 aggregation and nIB formation. This was most prominent for mutant p53, but could also be observed in wild-type p53 cell lines, for which nIB formation correlated with the loss of p53's transcriptional activity. Importantly, protein aggregation also fuelled the dysregulation of the proteostasis network in the tumour cell by inducing a hyperactivated, oncogenic heat-shock response, to which tumours are commonly addicted, and by overloading the proteasomal degradation system, an observation that was most pronounced for structurally destabilized mutant p53. Patients showing tumours with p53-positive nIBs suffered from a poor clinical outcome, similar to those with loss of p53 expression, and tumour biopsies showed a differential proteostatic expression profile associated with p53-positive nIBs. p53-positive nIBs therefore highlight a malignant state of the tumour that results from the interplay between (1) the functional inactivation of p53 through mutation and/or aggregation, and (2) microenvironmental stress, a combination that catalyses proteostatic dysregulation. This study highlights several unexpected clinical, biological and therapeutically unexplored parallels between cancer and neurodegeneration. Copyright (C) 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:24 / 38
页数:15
相关论文
共 65 条
[1]   p21 in cancer: intricate networks and multiple activities [J].
Abbas, Tarek ;
Dutta, Anindya .
NATURE REVIEWS CANCER, 2009, 9 (06) :400-414
[2]   Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment [J].
Alexandrova, E. M. ;
Yallowitz, A. R. ;
Li, D. ;
Xu, S. ;
Schulz, R. ;
Proia, D. A. ;
Lozano, G. ;
Dobbelstein, M. ;
Moll, U. M. .
NATURE, 2015, 523 (7560) :352-+
[3]   Adaptation to stressors by Systemic Protein Amyloidogenesis [J].
Audas, Timothy E. ;
Audas, Danielle E. ;
Jacob, Mathieu D. ;
Ho, J. J. David ;
Khacho, Mireille ;
Wang, Miling ;
Perera, J. Kishan ;
Gardiner, Caroline ;
Bennett, Clay A. ;
Head, Trajen ;
Kryvenko, Oleksandr N. ;
Jorda, Merce ;
Daunert, Sylvia ;
Malhotra, Arun ;
Trinkle-Mulcahy, Laura ;
Gonzalgo, Mark L. ;
Lee, Stephen .
DEVELOPMENTAL CELL, 2016, 39 (02) :155-168
[4]   Impairment of the ubiquitin-proteasome system by protein aggregation [J].
Bence, NF ;
Sampat, RM ;
Kopito, RR .
SCIENCE, 2001, 292 (5521) :1552-1555
[5]   PML regulates p53 stability by sequestering Mdm2 to the nucleolus [J].
Bernardi, R ;
Scaglioni, PP ;
Bergmann, S ;
Horn, HF ;
Vousden, KH ;
Pandolfi, PP .
NATURE CELL BIOLOGY, 2004, 6 (07) :665-672
[6]   Heat Shock Response Activation Exacerbates Inclusion Body Formation in a Cellular Model of Huntington Disease [J].
Bersuker, Kirill ;
Hipp, Mark S. ;
Calamini, Barbara ;
Morimoto, Richard I. ;
Kopito, Ron R. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (33) :23633-23638
[7]   Mutant p53 Aggregates into Prion-like Amyloid Oligomers and Fibrils IMPLICATIONS FOR CANCER [J].
Bom, Ana P. D. Ano ;
Rangel, Luciana P. ;
Costa, Danielly C. F. ;
de Oliveira, Guilherme A. P. ;
Sanches, Daniel ;
Braga, Carolina A. ;
Gava, Lisandra M. ;
Ramos, Carlos H. I. ;
Cepeda, Ana O. T. ;
Stumbo, Ana C. ;
De Moura Gallo, Claudia V. ;
Cordeiro, Yraima ;
Silva, Jerson L. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (33) :28152-28162
[8]   Structural, morphological, and functional diversity of amyloid oligomers [J].
Breydo, Leonid ;
Uversky, Vladimir N. .
FEBS LETTERS, 2015, 589 (19) :2640-2648
[9]   When mutants gain new powers: news from the mutant p53 field [J].
Brosh, Ran ;
Rotter, Varda .
NATURE REVIEWS CANCER, 2009, 9 (10) :701-713
[10]   Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy [J].
Bullock, AN ;
Henckel, J ;
Fersht, AR .
ONCOGENE, 2000, 19 (10) :1245-1256